Use of bupleurum root total polyoses in the preparing of medicine for preventing and treating systematic lupus erythematosus
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- FUDAN UNIV
- Publication Date
- 2008-01-02
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of traditional Chinese medicine, and relates to a new medical application of total polysaccharide of Bupleurum bupleuri. It specifically relates to the use of Bupleurum total polysaccharides in the preparation of medicines for preventing and treating systemic lupus erythematosus. Background technique:
[0002] Systemic lupus erythematosus (SLE) is an inflammatory connective tissue disease with unclear etiology. It mainly affects women and can also affect children. A multi-country and multi-center study showed that the current incidence of systemic lupus erythematosus is 12.5 / 100,000 to 39 / 100,000. SLE is generally regarded as a representative autoimmune disease, and it is a severe autoimmune disease that is refractory, recurrent, and has a high fatality rate. The phenotype of autoimmune abnormalities in SLE is highly diverse, almost involving the entire immune system, including immune tolerance defect, lymphocyte ap...